A study to compare the efficacy of two different volumes of injection Ropivacaine in brachial plexus block in upper limb surgeries

A Comparative Study between two different volumes of 0.5% Ropivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries. A randomized control study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055520

Enrollment

Registered

2023-07-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S62- Fracture at wrist and hand level Health Condition 2: S525- Fracture of lower end of radius Health Condition 3: S526- Fracture of lower end of ulna Health Condition 4: S523- Fracture of shaft of radius Health Condition 5: S522- Fracture of shaft of ulna Health Condition 6: S521- Fracture of upper end of radius Health Condition 7: S520- Fracture of upper end of ulna Health Condition 8: S568- Injury of other muscles, fascia and tendons at forearm level

Interventions

Intervention1: Injection Ropivacaine 0.5% given as local anaesthetic in supra clavicular brachial plexus block: To compare Injection Ropivacaine 0.5% 30ml with Injection Ropivacaine 0.5% 20ml as local

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients aged between 18-60 years American Society of Anesthesiologists Physical Status I and II Scheduled for elective upper limb surgeries under Supraclavicular block Body weight between 50-80 kgs.

Exclusion criteria

Exclusion criteria: Lack of patient consent ASA grade III, IV, V Patients with anticipated difficult intubation- Mallampati Grade 3 and 4 Any other Co-morbidities (COPD, Ischemic Heart Disease, Hypertension, Diabetes Mellitus, Renal & hepatic Dysfunction, etc.) Allergic to local anesthetics Coagulation disorder Pregnancy Body weight less than 50 kgs and more than 80 kgs Emergency surgeries

Design outcomes

Primary

Measure	Time frame
Time of onset of Motor block & Sensory block Duration of Motor block & Sensory block Time taken for first analgesic doseTimepoint: 24months	—

Secondary

Measure	Time frame
Any side effects Haemodynamic stabilityTimepoint: 24months	—

Countries

India

Contacts

Public ContactDishesh Sharda

Pacific Medical College And Hospital

prakash.audichya10@gmail.com9929721889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026